130 related articles for article (PubMed ID: 12382667)
1. Engineering of human hepatocyte lines for cell therapies in humans: prospects and remaining hurdles.
Kobayashit N; Tanaka N
Cell Transplant; 2002; 11(5):417-20. PubMed ID: 12382667
[TBL] [Abstract][Full Text] [Related]
2. Engineering of Human Hepatocyte Lines for Cell Therapies in Humans: Prospects and Remaining Hurdles.
Kobayashi N; Tanaka N
Cell Transplant; 2002 Jul; 11(5):417-420. PubMed ID: 28866930
[TBL] [Abstract][Full Text] [Related]
3. A reversibly immortalized human hepatocyte cell line as a source of hepatocyte-based biological support.
Kobayashi N; Westerman KA; Tanaka N; Fox IJ; Leboulch P
Addict Biol; 2001 Sep; 6(4):293-300. PubMed ID: 11900607
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte transplantation: waiting for stem cells.
Haridass D; Narain N; Ott M
Curr Opin Organ Transplant; 2008 Dec; 13(6):627-32. PubMed ID: 19060554
[TBL] [Abstract][Full Text] [Related]
5. Isolation of human hepatocytes from livers rejected for liver transplantation on a national basis: results of a 2-year experience.
Baccarani U; Sanna A; Cariani A; Sainz-Barriga M; Adani GL; Zambito AM; Piccolo G; Risaliti A; Nanni-Costa A; Ridolfi L; Scalamogna M; Bresadola F; Donini A
Liver Transpl; 2003 May; 9(5):506-12. PubMed ID: 12740795
[TBL] [Abstract][Full Text] [Related]
6. Successful retroviral gene transfer of simian virus 40 T antigen and herpes simplex virus-thymidine kinase into human hepatocytes.
Kobayashi N; Noguchi H; Westerman KA; Watanabe T; Matsumura T; Totsugawa T; Fujiwara T; Leboulch P; Tanaka N
Cell Transplant; 2001; 10(4-5):377-81. PubMed ID: 11549057
[TBL] [Abstract][Full Text] [Related]
7. Human hepatocyte transplantation: state of the art.
Fitzpatrick E; Mitry RR; Dhawan A
J Intern Med; 2009 Oct; 266(4):339-57. PubMed ID: 19765179
[TBL] [Abstract][Full Text] [Related]
8. Establishment of immortalized human hepatocytes by introduction of HPV16 E6/E7 and hTERT as cell sources for liver cell-based therapy.
Tsuruga Y; Kiyono T; Matsushita M; Takahashi T; Kasai H; Matsumoto S; Todo S
Cell Transplant; 2008; 17(9):1083-94. PubMed ID: 19177844
[TBL] [Abstract][Full Text] [Related]
9. Hybrid bioartificial liver: establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use.
Kobayashi N; Okitsu T; Nakaji S; Tanaka N
J Artif Organs; 2003; 6(4):236-44. PubMed ID: 14691665
[TBL] [Abstract][Full Text] [Related]
10. Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo.
Duan Y; Catana A; Meng Y; Yamamoto N; He S; Gupta S; Gambhir SS; Zern MA
Stem Cells; 2007 Dec; 25(12):3058-68. PubMed ID: 17885076
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte transplantation for the treatment of human disease.
Strom SC; Chowdhury JR; Fox IJ
Semin Liver Dis; 1999; 19(1):39-48. PubMed ID: 10349682
[TBL] [Abstract][Full Text] [Related]
12. Historical aspects of hepatocyte transplantation.
Bruzzone P; Strom SC
Transplant Proc; 2006 May; 38(4):1179-80. PubMed ID: 16757299
[TBL] [Abstract][Full Text] [Related]
13. [Transplantation of hepatocytes--present status and future perspectives].
Smrzová J; Ulrichová J; Dítĕ P; Lata J
Vnitr Lek; 2001 Nov; 47(11):790-6. PubMed ID: 11795187
[TBL] [Abstract][Full Text] [Related]
14. Prospects for cell-based therapies for liver disease.
Min AD; Theise ND
Panminerva Med; 2004 Mar; 46(1):43-8. PubMed ID: 15238880
[TBL] [Abstract][Full Text] [Related]
15. Immortalized p19ARF null hepatocytes restore liver injury and generate hepatic progenitors after transplantation.
Mikula M; Fuchs E; Huber H; Beug H; Schulte-Hermann R; Mikulits W
Hepatology; 2004 Mar; 39(3):628-34. PubMed ID: 14999681
[TBL] [Abstract][Full Text] [Related]
16. Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with Tamoxifen-mediated self-recombination.
Totsugawa T; Yong C; Rivas-Carrillo JD; Soto-Gutierrez A; Navarro-Alvarez N; Noguchi H; Okitsu T; Westerman KA; Kohara M; Reth M; Tanaka N; Leboulch P; Kobayashi N
J Hepatol; 2007 Jul; 47(1):74-82. PubMed ID: 17434229
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of hepatocytes derived from early ES cells and treatment of surgically induced liver failure rats by transplantation.
Tabei I; Hashimoto H; Ishiwata I; Tachibana T; Akahori M; Ohi S; Kubo H; Satou K; Yamazaki Y; Yanaga K; Ishikawa H
Transplant Proc; 2005; 37(1):262-4. PubMed ID: 15808614
[TBL] [Abstract][Full Text] [Related]
18. Genetic modification of hepatocytes towards hepatocyte transplantation and liver tissue engineering.
Kuge H; Ohashi K; Yokoyama T; Kanehiro H; Hisanaga M; Koyama F; Bumgardner GL; Kosai K; Nakajima Y
Cell Transplant; 2006; 15(1):1-12. PubMed ID: 16700325
[TBL] [Abstract][Full Text] [Related]
19. Human hepatocyte transplantation for acute liver failure: state of the art and analysis of cell sources.
Baccarani U; Adani GL; Sainz M; Donini A; Risaliti A; Bresadola F
Transplant Proc; 2005; 37(6):2702-4. PubMed ID: 16182789
[TBL] [Abstract][Full Text] [Related]
20. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure.
Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kato T; Okochi H; Ochiya T
J Gastroenterol Hepatol; 2009 Jan; 24(1):70-7. PubMed ID: 18624899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
